Acquired Glanzmann´s thrombasthenia variant and immune thrombocytopenia in a renal transplant recipient receiving tacrolimus

Christian Morath; Till Hoffmann; Elisabeth M. Kirchhoff; Jeanne Sis; Martin Zeier; Rüdiger E. Scharf; Konrad Andrassy

doi:10.1055/s-0037-1615580

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 94(04): 879-880
DOI: 10.1055/s-0037-1615580

Case Report

Schattauer GmbH

Acquired Glanzmann´s thrombasthenia variant and immune thrombocytopenia in a renal transplant recipient receiving tacrolimus

Authors

Christian Morath

¹Department of Nephrology, University of Heidelberg, Heidelberg, Germany
Till Hoffmann

²Department of Hemostasis and Transfusion Medicine, University of Düsseldorf, Düsseldorf, Germany
Elisabeth M. Kirchhoff

²Department of Hemostasis and Transfusion Medicine, University of Düsseldorf, Düsseldorf, Germany
Jeanne Sis

¹Department of Nephrology, University of Heidelberg, Heidelberg, Germany
Martin Zeier

¹Department of Nephrology, University of Heidelberg, Heidelberg, Germany
Rüdiger E. Scharf

²Department of Hemostasis and Transfusion Medicine, University of Düsseldorf, Düsseldorf, Germany
Konrad Andrassy

¹Department of Nephrology, University of Heidelberg, Heidelberg, Germany

Abstract

Full Text

References

References
1 Malik U, Dutcher JP, Oleksowicz L. Acquired Glanzmann’s thrombasthenia associated with Hodgkin’s lymphoma: a case report and review of the literature. Cancer 1998; 82: 1764-8.
2 Christie DJ, Sauro SC, Cavanaugh AL. et al. Severe thrombocytopenia in an acquired immunodeficiency syndrome patient associated with pentamidine-dependent antibodies specific for glycoprotein IIb/IIIa. Blood 1993; 82: 3075-80.
3 Gottschall JL, Elliot W, Lianos E. et al. Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity. Blood 1991; 77: 306-10.
4 Bettaieb A, Fromont P, Louache F. et al. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIVrelated immune thrombocytopenic purpura. Blood 1992; 80: 162-9.
5 Scharf RE, Tomer A, Marzec UM. et al. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992; 12: 1475-87.
6 Scharf RE. Molecular basis and clinical aspects of hereditary megakaryocyte and platelet membrane glycoprotein disorders. Hämostaseologie 1996; 16: 114-38.
7 Shinohara K, Okafuji K, Ayame H. et al. Aplastic anemia caused by allopurinol in renal insufficiency. Am J Hematol 1990; 35: 68.
8 Lin YW, Okazaki S, Hamahata K. et al. Acute pure red cell aplasia associated with allopurinol therapy. Am J Hematol 1999; 61: 209-11.
9 Rawal A, Sarode R, Curtis BR. et al. Acquired Glanzmann’s thrombasthenia as part of multiple-autoantibody syndrome in a pediatric heart transplant patient. J Pediatr 2004; 144: 672-4.
10 Prieto J, Yuste JR, Beloqui O. et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23: 199-204.
11 Granel B, Swiader L, Veit V. et al. [Pseudo-Glanzmann thrombasthenia in the course of autoimmune thrombocytopenic purpura]. Rev Med Interne 1998; 19: 823-5.